[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]
@BioStocks Bio Stocks™
Bio Stocks™ posts on X about $srpt, $abvx, $mdgl, $arwr the most. They currently have XXXXXX followers and XXX posts still getting attention that total XXXXXX engagements in the last XX hours.
Engagements: XXXXXX #
- X Week XXXXXXX +25%
- X Month XXXXXXX +22%
- X Months XXXXXXXXX +12%
- X Year XXXXXXXXX +0.65%
Mentions: XX #
- X Week XX -XXXX%
- X Month XXX +32%
- X Months XXX +12%
- X Year XXXXX +66%
Followers: XXXXXX #
- X Week XXXXXX +0.27%
- X Month XXXXXX +0.71%
- X Months XXXXXX +2.20%
- X Year XXXXXX +4.50%
CreatorRank: XXXXXXX #
Social Influence #
Social category influence finance #2687 stocks XXXXX% currencies XXXX% countries XXXX% cryptocurrencies XXXX% exchanges XXXX%
Social topic influence $srpt #1, $abvx #4, $mdgl #7, $arwr #1, bla 1.6%, $bmy 1.06%, $alks 1.06%, morgan stanley 1.06%, $lly 1.06%, weight loss XXXX%
Top accounts mentioned or mentioned by @biotechtoast @biopharmiq @thenorthstar5 @grok @pawcio2009 @value_econ @bluemoontrades @dace0325 @a_may_md @superrfly @xai @msollender @king @aaaamhim @warrenbufftrade @_joebaffoe @persimmonti @rnaianalyst @pissedwhitedude @luciusjameson
Top assets mentioned Sarepta Therapeutics, Inc. (SRPT) Madrigal Pharmaceuticals, Inc. Common Stock (MDGL) Arrowhead Research Corporation (ARWR) Bristol-Myers Squibb Co (BMY) Alkermes Inc. plc (ALKS) Morgan Stanley (MS) Eli Lilly and Company (LLY) Novo-Nordisk (NVO) Viking Therapeutics, Inc (VKTX) AstraZeneca PLC (AZN) BridgeBio Pharma, Inc. Common Stock (BBIO) Pfizer, Inc. (PFE) Goldman Sachs (GS) Recursion Pharmaceuticals, Inc. Class A Common Stock (RXRX) Oscar Health, Inc. (OSCR) Amgen, Inc. (AMGN) Jazz Pharmaceuticals, Inc. (JAZZ) Amicus Therapeutics, Inc (FOLD) Passage (PASG) Hundred Million (100M) AbbVie Inc (ABBV) Dyne Therapeutics, Inc. Common Stock (DYN) Moderna Inc (MRNA) Scholar Rock Holding Corporation Common Stock (SRRK)
Top Social Posts #
Top posts by engagements in the last XX hours
"$PFE $BMY to Launch Direct-to-Consumer Sales of Eliquis. Eliquis has a list price of $XXX for a 30-day supply but will now offer a discounted cash price of $XXX a month"
@BioStocks on X 2025-07-17 10:35:25 UTC 68.5K followers, 5082 engagements
"$ALKS initiated with a Buy at Goldman Sachs. PT $43" @BioStocks on X 2025-07-15 12:31:33 UTC 68.5K followers, 3974 engagements
"$ABSI initiated with an Overweight at Morgan Stanley. PT $X. $RXRX" @BioStocks on X 2025-07-03 10:50:42 UTC 68.5K followers, 4968 engagements
"$MDGL Receives Notice of Allowance from U.S. Patent and Trademark Office for New U.S. Patent Covering Rezdiffra. Provides Protection Through Sept. 2044; Will Be Listed in FDAs Orange Book" @BioStocks on X 2025-07-16 12:02:07 UTC 68.6K followers, 13.5K engagements
"$OSCR Announces Preliminary Financial Results for Q2 and Revises FY'25 Guidance. - Raises FY'25 Rev from $11.2B - $11.3B to $12B-$12.2B - Expects Q2 net loss of $228M" @BioStocks on X 2025-07-22 10:08:57 UTC 68.6K followers, 32.6K engagements
"New weight loss drug data show Eli Lilly is gaining ground. $LLY $NVO $AMGN $VKTX" @BioStocks on X 2025-07-05 14:06:56 UTC 68.5K followers, 4518 engagements
"$ATYR Announces Last Patient Visit in Phase X EFZO-FIT Study of Efzofitimod in Patients with Pulmonary Sarcoidosis. Topline Data Q3 🔥" @BioStocks on X 2025-07-22 12:01:17 UTC 68.6K followers, 15.2K engagements
"$JAZZ names Renee Gala as President and CEO" @BioStocks on X 2025-07-10 11:40:12 UTC 68.6K followers, 3208 engagements
"$AZN plans to invest $XX billion in America for medicines manufacturing and R&D" @BioStocks on X 2025-07-21 22:35:39 UTC 68.6K followers, 4758 engagements
"$ARWR Issues Statement on the Status of its Ongoing Agreement with $SRPT" @BioStocks on X 2025-07-23 12:01:05 UTC 68.6K followers, 11.4K engagements
"$SRPT downgraded to Sell at Deutsche Bank. PT $9" @BioStocks on X 2025-07-19 12:19:41 UTC 68.5K followers, 8148 engagements
"$SRPT Third death from a Sarepta gene therapy. The patient was in a trial of the companys limb-girdle muscular dystrophy gene therapy" @BioStocks on X 2025-07-18 01:02:31 UTC 68.6K followers, 17.6K engagements
"$FOLD upgraded to Overweight at Morgan Stanley. PT $12" @BioStocks on X 2025-07-16 22:55:11 UTC 68.5K followers, 3687 engagements
"$BMY Phase X INDEPENDENCE Trial for Reblozyl in Adult Patients with Myelofibrosis-Associated Anemia Did Not Meets its Primary Endpoint" @BioStocks on X 2025-07-18 11:01:44 UTC 68.5K followers, 7483 engagements
"$ARWR should Sarepta fail to make either the $100M or $200M near-term payment associated with enrollment of ARO-DM1 cohorts or fail to make any development or commercial milestone payment Arrowhead would have the right to terminate the agreement. $SRPT" @BioStocks on X 2025-07-23 12:11:04 UTC 68.6K followers, 3131 engagements
"$PEAR Pear Therapeutics to go public in $XXX billion SPAC merger with Thimble Point Acquisition $THMA" @BioStocks on X 2021-06-22 11:26:39 UTC 68.5K followers, XX engagements
"$ABBV and Ichnos Glenmark Innovation (IGI) Announce Exclusive Global Licensing Agreement for ISB 2001 a First-in-Class CD38BCMACD3 Trispecific Antibody. IGI will receive an upfront payment of $700M + up to $1.25B in milestone payments" @BioStocks on X 2025-07-10 11:39:03 UTC 68.6K followers, 25.4K engagements
"$BBIO initiated with a Buy Truist. PT $66" @BioStocks on X 2025-07-21 12:00:34 UTC 68.6K followers, 3491 engagements
"$JSPR XX% workforce reduction. Halting ETESIAN study in asthma the SCID study and the ongoing investigator-sponsored studies. CMO departing" @BioStocks on X 2025-07-09 12:10:14 UTC 68.5K followers, 4022 engagements
"$SRPT Q2 total net product revenue: $513M ELEVIDYS net product revenue: $282M RNA-based PMOs net product revenue: $231M Cash cash equivalents: $850M Expects to submit the BLA for SRP-9003 for LGMD type 2E/R4 in 2H'25" @BioStocks on X 2025-07-16 23:06:41 UTC 68.5K followers, 9297 engagements
"$CRDL Announces Database Lock for Phase X ARCHER Trial of CardiolRx(TM) in Acute Myocarditis. Topline data expected within the next two weeks" @BioStocks on X 2025-07-22 11:38:42 UTC 68.6K followers, 5593 engagements
"$MRNA Receives Full FDA Approval for Spikevax in Children Aged X Months Through XX Years at Increased Risk for #COVID19 Disease" @BioStocks on X 2025-07-10 12:34:15 UTC 68.5K followers, 5276 engagements
"$CLSD Announces Plan to Explore Strategic Alternatives Will pause all internal research and development programs. All employees including the CEO CFO and CMO will transition into consulting roles with the Company" @BioStocks on X 2025-07-17 11:09:03 UTC 68.6K followers, 3832 engagements
"Weight loss drugs could be a game-changer for women with PCOS. $LLY $NVO $VKTX" @BioStocks on X 2025-07-20 16:22:49 UTC 68.6K followers, 13.6K engagements
"$BBIO initiated with a Buy at Jefferies. PT $70" @BioStocks on X 2025-07-14 10:26:29 UTC 68.6K followers, 8321 engagements
"$MESO and FDA Align on Key Items for Revascor BLA in Ischemic Heart Failure. Intends to file BLA by EOY for accelerated approval" @BioStocks on X 2025-07-01 00:47:35 UTC 68.5K followers, 5119 engagements
"$ARWR Sarepta has provided no indication of any intention to fail to fulfill any of its obligations however if that occurs there are clear termination provisions that would cause assets and associated intellectual property to be returned to Arrowhead. $SRPT" @BioStocks on X 2025-07-23 12:02:29 UTC 68.6K followers, 3715 engagements
"$SONN The newly-created entity is to be named Hyperliquid Strategies Inc (HSI) which is expected to hold approximately 12.6M HYPE tokens representing $583M in value and gross cash invested of at least $305M for a total assumed closing value of $888M" @BioStocks on X 2025-07-14 10:03:14 UTC 68.6K followers, 2992 engagements
"$MDGL Secures $500M in Senior Secured Credit from Blue Owl Managed Funds to Further Extend Leadership Position in MASH" @BioStocks on X 2025-07-22 12:02:45 UTC 68.6K followers, 8039 engagements
"$ANEB Board has approved as part of a going private transaction a reverse stock split at a ratio of not less than 1-for-2500 and not greater than 1-for-7500. Stockholders will receive $XXXX cash per pre-split share - XX% premium" @BioStocks on X 2025-07-23 12:07:06 UTC 68.6K followers, 2387 engagements
"$ALKS Announces Positive Topline Results From Vibrance-1 Phase X Study of Once-Daily Alixorexton in Patients With Narcolepsy Type 1" @BioStocks on X 2025-07-21 10:01:06 UTC 68.6K followers, 5881 engagements
"$DMAC Reports Positive Interim Phase X Preeclampsia Results: Statistically Significant Reductions in Blood Pressure and No Placental Transfer" @BioStocks on X 2025-07-17 12:07:18 UTC 68.6K followers, 4553 engagements
"$AUTL AUCATZYL Granted European Marketing Authorization for Adult Patients (age XX and older) with Relapsed or Refractory B-Cell Precursor Acute Lymphoblastic Leukemia" @BioStocks on X 2025-07-21 11:49:09 UTC 68.6K followers, 3596 engagements
"$AZN Baxdrostat met the primary and all secondary endpoints in BaxHTN Phase X trial in patients with uncontrolled or treatment resistant hypertension. $CINC" @BioStocks on X 2025-07-14 11:02:37 UTC 68.5K followers, 4114 engagements
"$SONN Sonnet BioTherapeutics Announces $888M Business Combination to Launch a HYPE Cryptocurrency Treasury Reserve Strategy" @BioStocks on X 2025-07-14 10:01:41 UTC 68.6K followers, 33.9K engagements